Here are relevant reports on : regenerative-medicine-market
-
Regenerative Medicine Market by Product (Stem Cell [Autologous, Allogenic], Immunotherapy, Gene Therapy, Tissue Engineering), Application (Musculoskeletal, Cancer, Dermatology, Wound care, Cardiovascular Diseases, Eye Disorders) & Region - Global Forecast to 2028
The global regenerative medicine market growth is primed to transition from USD 16.0 billion in 2023 to USD 49.0 billion by 2028, showcasing a strong CAGR of 25.1%. The growth of this market is characterized by the increasing collaborations and partnerships by major market players, and the emerging applications in new therapeutic areas. Rising focus on personalized medicine and increasing regulatory approvals in regenerative medicine are also predicted to drive the market.
- Published: January 2024
- Price: $ 4950
- TOC Available:
-
In Vitro Lung Model Market by Type (2D, 3D (In-house, Commercial)), Application (Drug Screening, Toxicology, 3D Model Development, Basic Research, Physiologic Research, Stem Cell Research, Regenerative Medicine) - Global Forecasts to 2023
The lung in vitro models market is projected to reach USD 427.4 Million by 2023, at a CAGR of 17.5%. The key factors driving the growth of this market include growing focus on developing alternatives for animal testing models, advancements in Cell Culture technologies, and the development of new 3D in vitro models. The major players in the Lung in vitro models market include Epithelix (Switzerland), MatTek Corporation (US), Lonza (Switzerland), ATCC (US), InSphero (Switzerland), Emulate (US), AlveoliX (Switzerland), Oncotheis (Switzerland), Insphero (Switzerland), TissUse (Switzerland), Mimetas (Netherlands), and CN Bio Innovations (UK).
- Published: April 2018
- Price: $ 11000
- TOC Available:
-
Biobanking Market by Product & Service (Equipment, Consumable, Services, Software), Sample Type (Blood, Tissue, Nucleic Acids, Cell lines), Ownership, Application (Regenerative Medicine, Life Science, Clinical Research), End User - Global Forecast to 2028
The global biobanking market in terms of revenue was estimated to be worth $2.9 billion in 2023 and is poised to reach $5.0 billion by 2028, growing at a CAGR of 11.4% from 2023 to 2028. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market.
- Published: May 2023
- Price: $ 4950
- TOC Available:
-
Stem Cell Assays Market Size by Type (Viability, Proliferation, Differentiation, Apoptosis), Cell Type (Mesenchymal, iPSCs, HSCs, hESCs), Product & Service (Instrument), Application (Regenerative Medicine, Clinical Research), End User - Global Forecast to 2027
The size of global stem cell assays market in terms of revenue was estimated to be worth USD 1.9 billion in 2022 and is poised to reach USD 4.5 billion by 2027, growing at a CAGR of 17.7% from 2022 to 2027. The research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market.
- Published: June 2022
- Price: $ 4950
- TOC Available:
-
Human Organoids Market by Product (Pancreas, Kidney, Lung, GIT, Liver Models) Usabilty (Customized, Ready-To-Use), Application (Toxicity, Pathology, Personalized & Regenerative Medicine), Enduser (Pharma-Biotech, CROs, Academia) - Global Forecast to 2025
The human organoids market size is projected to reach USD 1,901 million by 2025, at a CAGR of 17.5%. Prominent players in this market BioIVT (US), Thermo Fisher Scientific (US), ZenBio (US), Corning (US), Organovo (US), Cyprio (France), Biopredic International (France), CELLINK (Sweden), Emulate (US), Hµrel Corporation (US), InSphero (Switzerland), Kerafast (US), Kirkstall (UK), and MIMETAS (Netherlands).
- Published: December 2020
- Price: $ 4950
- TOC Available:
-
Cell Culture Market by Product (Consumables (Media, Sera, Reagents), Vessels (Roller Bottle, Cell Factory, Flask), Equipment (SU Bioreactor, Storage, Incubators, Filtration)), Application (mAbs, Vaccines, Regenerative Medicine) & Region - Global Forecast to 2029
The global cell culture market in terms of revenue was estimated to be worth $30.9 billion in 2024 and is poised to reach $57.9 billion by 2029, growing at a CAGR of 13.4% from 2024 to 2029. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market.
- Published: March 2024
- Price: $ 4950
- TOC Available:
-
Cell Line Development Market by Product (Equipment, Media and Reagents), Source, type & by Application ( Bioproduction, Tissue Engineering & Regenerative medicine, Toxicity Testing, Research, Drug Discovery) - Analysis & Global Forecast to 2019
The global cell line development market is expected to reach 3.96 billion by 2019 from $2.2 billion in 2014, and is expected to grow at a CAGR of 12.5% from 2014 to 2019. The market is dominated by North America, followed by Europe, Asia, and Rest of the World (RoW). North America is expected to maintain its leadership position in the market in the coming years.
- Published: September 2014
- Price: $ 4950
- TOC Available:
-
3D Bioprinting Market by Component (3D bioprinters (Microextrusion, Inkjet, Laser), Bioinks, Software, Consumable), Material (Hydrogels, ECM), Application (Research (Regenerative Medicine, 3D cell Culture), Clinical (Skin, Bone)) - Global Forecast to 2029
The global 3D bioprinting market growth is primed to transition from USD 1.3 billion in 2024 to USD 2.4 billion by 2029, showcasing a strong CAGR of 12.7%. The market growth is fueled by growing adoption of 3D bioprinting technology in the pharmaceutical and cosmetic industries, technological advancement in the 3D bioprinting and rising demand for organ transplants.
- Published: May 2024
- Price: $ 4950
- TOC Available:
-
Personalized Medicine Market by Product (Personalized Medicine Testing, Personalized Medicine Therapeutics), Application (Oncology, Neurology, Cardiology) - Global Forecast to 2027
The global personalized medicine market is projected to reach USD ~500 billion by 2027 from USD 300 Billion in 2022, at a CAGR of 11% during the forecast period
- Published: December 2024
- Price: $ 4950
- TOC Available:
-
Virtual Care Market by Component (Software & Services, Hardware), Consultation Type (Video, Audio, Messaging), Application (Family Medicine, Internal Medicine, Pediatrics), End User (Hospital & Clinics, Pharmacies) & Region - Global Forecasts to 2030
The global virtual care market size is projected to reach $76.9 billion by 2030 from an estimated $8.4 billion in 2022, at a CAGR of 32.1%. The virtual care market is mainly driven by factors such as the increasing need to expand healthcare access especially in the rural areas, growing number of patient population worldwide, a shortage of physicians, advancements in telecommunications and the increasing adoption of digital healthcare services. However, regulatory disparity and reimbursement issues pertaining to virtual care are expected to restrain the growth of this market to a certain extent in the coming years.
- Published: December 2024
- Price: $ 4950
- TOC Available:
Records 1 to 10 of 50
